Is Vertex Pharmaceuticals Stock a Buy in 2025?
The bottom line is few companies can match its combination of established leadership in rare diseases and realistic pathways ...
BioPharma Dive4d
A new, non-opioid pain drug is here. Getting it to patients could be agony.
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
Nasdaq10d
Is Vertex Pharmaceuticals Stock a Buy in 2025?
Wall Street sees plenty of growth ahead, projecting an 8.2% jump in sales for 2025 as new products gain traction ... dollar markets, Vertex offers a compelling mix of stability and upside potential.
The Armenian Reporter20h
Pharmaceutical Stocks Worth Watching – February 01st
AbbVie, Eli Lilly and Company, Vertex Pharmaceuticals, Thermo Fisher Scientific, and Johnson & Johnson are the five ...
The Armenian Reporter19h
Medical Stocks To Keep An Eye On – February 01st
UnitedHealth Group, AbbVie, Eli Lilly and Company, Vertex Pharmaceuticals, and Walmart are the five Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks refer ...
pharmaphorum4d
UK to crack down on generics price gouging
In a briefing document, the Department of Health said that it cannot currently control the price of a generic medicine if a manufacturer has a mix of branded and unbranded products, and the ...
pharmaphorum3d
4 principles for the future of pharma marketing
In this feature, Grünenthal's Florent Edouard and Kate Hurtig outline their principles for a new pharmaceutical marketing ... excellence has been very product-driven. But that approach has ...
Nature28d
Public biotech 2006—the numbers
Peptide drug developer Affymax (Palo Alto, CA, USA), which in 2006 clinched a global agreement with Takeda Pharmaceuticals (Tokyo) for the development and commercialization of its lead product ...